why choose us

First received: July 9, 2022

Clinical Trial: Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

Study Status: Completed

Recruit Status: Completed

Condition: Stem Cell Infusion

Study Type: Interventional


Official Title: Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequela in Children With Spina Bifida

Brief Summary: The aim of this study was to evaluate the safety and efficacy of autologous bone marrow mononuclear cell infusion in the management of neurological sequelae in children with spina bifida

Read more